Page last updated: 2024-09-05

cyclo(glutamyl-alanyl-isoleucyl-leucyl-tryptophyl) and Myocardial Ischemia

cyclo(glutamyl-alanyl-isoleucyl-leucyl-tryptophyl) has been researched along with Myocardial Ischemia in 1 studies

*Myocardial Ischemia: A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries (CORONARY ARTERY DISEASE), to obstruction by a thrombus (CORONARY THROMBOSIS), or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (MYOCARDIAL INFARCTION). [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cioffi, MA; Forbess, J; Hiramatsu, T; Mayer, JE; Miura, T; Roth, SJ1

Other Studies

1 other study(ies) available for cyclo(glutamyl-alanyl-isoleucyl-leucyl-tryptophyl) and Myocardial Ischemia

ArticleYear
Effects of endothelin-1 and endothelin-A receptor antagonist on recovery after hypothermic cardioplegic ischemia in neonatal lamb hearts.
    Circulation, 1995, Nov-01, Volume: 92, Issue:9 Suppl

    Topics: Animals; Biological Assay; Coronary Circulation; Endothelin Receptor Antagonists; Endothelins; Heart; Heart Arrest, Induced; Hypothermia, Induced; Myocardial Ischemia; Oxygen Consumption; Peptides, Cyclic; Receptor, Endothelin A; Reference Values; Sheep; Ventricular Function, Left

1995